HEAR FROM PEOPLE
WHO ARE TAKING BRIUMVI
Discover how BRIUMVI is impacting real people with RMS. Hear from people who have included it in their RMS treatment journey.
HEAR FROM PEOPLE WHO ARE TAKING BRIUMVI
Discover how BRIUMVI is impacting real people with RMS. Hear from people who have included it in their RMS treatment journey.
HEAR FROM PEOPLE WHO ARE TAKING BRIUMVI
Discover how BRIUMVI is impacting real people with RMS. Hear from people who have included it in their RMS treatment journey.
These individual stories feature people who have taken BRIUMVI for their RMS – either as a first treatment or after trying other options. Hear why thousands of people, like Mandy, Alex and Meaghan, chose BRIUMVI to take on their RMS.
“When I found out that BRIUMVI was a 1-hour infusion twice a year after the starting dose, I was really drawn to choosing that as my DMT. I have two girls and it’s nice that I can get my infusions while they’re at school and it doesn’t interrupt my time with them.”
Mandy, Living with RMS and taking BRIUMVI
Individual results may vary
“Being on an effective medication for my RMS was important to me because I have two young daughters to raise. I feel like BRIUMVI is the right choice for me.”
Alex, Living with RMS and taking BRIUMVI
Individual results may vary
“Being on an effective medication for my RMS was important to me because I have two young daughters to raise. I feel like BRIUMVI is the right choice for me.”
Alex, Living with RMS and taking BRIUMVI
Individual results may vary
“I love doing anything I can possibly do outside. Aside from the 1-hour infusion time after the first dose, I did my own research, and I was impressed by the efficacy and the safety of BRIUMVI. That is what ultimately led my doctor and I to choose BRIUMVI.”
Meaghan, Living with RMS and taking BRIUMVI
Individual results may vary
See All Stories
SHARE YOUR BRIUMVI STORY
Interested in sharing your BRIUMVI experience with others?
BRIUMVI Patient Support
Discover a flexible program designed to support the treatment journey in a way that works best for you.
FINANCIAL ASSISTANCE
No matter what type of health insurance you have, there may be support to help you afford BRIUMVI. Options may be available for you even if you have no health insurance at all. Learn about the potential options.
People featured on this page are taking BRIUMVI and have been compensated by TG Therapeutics for their time.
INDICATION AND IMPORTANT
SAFETY INFORMATION
Who should not receive BRIUMVI?
What is the most important information I should know about BRIUMVI?
- fever
- chills
- headache
- flu-like symptoms
- fast heartbeat
- hives
- itchy skin
- dizziness
- feeling faint
- swelling of tongue or throat
- trouble breathing
- wheezing
- nausea
- abdominal pain
- throat irritation
- redness of the face or skin
These infusion reactions can happen over 24 hours after your infusion. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion. If you get an infusion reaction, your healthcare provider may need to stop or slow down the rate of your infusion.
- Infection:
- Infections are a common side effect, and upper respiratory tract infections are one of the most common side effects of BRIUMVI. BRIUMVI increases your risk of getting infections caused by bacteria or viruses that may be life-threatening or cause death. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, a cough that does not go away, or painful urination. Your healthcare provider should delay your treatment with BRIUMVI until your infection is gone.
- Hepatitis B virus (HBV) reactivation: Before starting treatment with BRIUMVI, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with BRIUMVI. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving BRIUMVI.
- Weakened immune system: BRIUMVI taken before or after other medicines that weaken the immune system could increase your risk of getting infections.
- Progressive Multifocal Leukoencephalopathy (PML): PML may happen with BRIUMVI. PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These symptoms may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory which may lead to confusion, and personality changes.
- Low immunoglobulins: BRIUMVI may cause a decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.
Before receiving BRIUMVI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of BRIUMVI?
Indication
